September 2026
The global generic injectable market size is expected to increase from USD 152.01 billion in 2026 and is expected to reach around USD 482.50 billion by 2035 with a CAGR of 13.72%.
September 2026
The generic sterile injectable market size is estimated to hit around USD 124.44 billion by 2035 increasing from USD 56.41 billion in 2026, with a CAGR of 9.29%.
June 2026
The U.S. generic sterile injectable market size was evaluated at USD 17.91 billion in 2025 and is predicted to hit around USD 43.26 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The global facial injectable market size is expected to increase from USD 16.15 billion in 2026 to hit around USD 44.05 billion by 2035, with a CAGR of 11.82%.
September 2026
The global non-injectable insulin market size is expected to increase from USD 2.13 billion in 2026 and is expected to hit around USD 5.63 billion by 2034 at a CAGR of 12.99%.
September 2026
The global generic pharmaceuticals contract manufacturing market size is projected to hit around USD 135.36 billion by 2034 from USD 85.96 billion in 2026 with a CAGR of 5.84%.
September 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
September 2026
The global injectable peptides drugs market size was evaluated at USD 53.07 billion in 2026 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
September 2026
The global injectable cytotoxic drugs market size is estimated to hit around USD 35.71 billion by 2034 increasing from USD 21.99 billion in 2026, with a CAGR of 6.25%.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
August 2026
The specialty generics market size was valued at USD 102.92 billion in 2025 and is expected to hit around USD 221.62 billion by 2035, growing at a CAGR of 7.97% from 2026 to 2035
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 5.19 billion in 2026, with a CAGR of 9.59%.
June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.70 billion in 2026, with a CAGR of 6.96%.
May 2026
The global aesthetic injectables market size is estimated to hit around USD 43.98 billion by 2035 increasing from USD 13.81 billion in 2025, with a CAGR of 12.28%.
February 2026
The U.S. generic drugs market size was exhibited at USD 146.04 billion in 2025 and is projected to hit around USD 243.70 billion by 2035 with a CAGR of 5.25%.
August 2025
The global long-acting injectables (LAIs) market size was evaluated at USD 16.94 billion in 2024 and is predicted to hit around USD 57.26 billion by 2034, growing at a CAGR of 12.95%.
July 2025
The inhalation and nasal spray generic drugs market size is projected to hit around USD 54.44 billion by 2034 from USD 27.38 billion in 2026, with a CAGR of 8.97%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com